Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices

Clinical trial NCT07352228 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07352228
Sponsor: Xijing Hospital
Status: ENROLLING_BY_INVITATION
Phase: Phase 4
Study type: INTERVENTIONAL

Rebleeding of Portal Hypertension in Liver Cirrhosis Propranolol Carvedilol

Start date: 2026-01-01
Primary completion: 2026-09-30
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.